Conference Highlights

Lung cancer screening (LCS) programs have demonstrated the ability to detect malignancies earlier, allowing for potentially curative treatment. Read More ›

A retrospective cohort study presented at the 2025 World Conference on Lung Cancer raises questions about the necessity of combining maintenance pemetrexed (Alimta) with pembrolizumab (Keytruda) in the treatment of advanced nonsquamous non–small cell lung cancer (NSCLC). Read More ›

Injectable GLP-1 drugs like semaglutide and tirzepatide may produce smaller weight loss in a “real-world” setting because patients may be more prone to discontinue treatment or use lower maintenance dosages than was used in clinical trials, according to recently published study results. Read More ›

Continuous glucose monitor (CGM)-derived metrics are going to continue to guide clinical decisions on patients with diabetes, and may have the potential to be even more impactful on the future of type 2 diabetes patients than even advancements in medication, according to 2 separately presented pieces of data at the 85th Scientific Sessions of the American Diabetes Association held in Chicago recently. Read More ›

More than 20% of Iraq and Afghanistan war veterans are reportedly suffering from post-traumatic stress disorder (PTSD), and more than 450,000 service members have been diagnosed with at least 1 traumatic brain injury over the past 20 years. Read More ›

Immune checkpoint inhibitors (ICIs) have altered the management of several cancers, including a subset of colorectal cancers (CRCs) characterized by deficient mismatch repair (dMMR) and microsatellite instability (MSI). Read More ›

Access to treatment and survival outcomes among US veterans with stage I non–small cell lung cancer (NSCLC) may vary depending on demographic and sociological patterns, according to a study presented at the 2025 ASCO Annual Meeting, held in Chicago, Illinois, from May 30 to June 3, and published simultaneously online. Read More ›

Access to treatment and survival outcomes among US veterans with stage I non–small cell lung cancer (NSCLC) may vary depending on demographic and sociological patterns, according to a study presented at the 2025 ASCO Annual Meeting. Read More ›

With more than 400 nominations this year, the AMSUS Award Ceremony underscored the dedication and excellence of healthcare professionals across federal service. Read More ›

What a way to begin March! At a time when federal healthcare is changing significantly, in large part due to President Donald Trump’s second nonconsecutive term election, AMSUS was perfectly timed. Read More ›